Torrent, Glenmark led Indian pharma market growth with their April sales rising 16.7-17.7% in value terms. Alkem also saw ...

NEW DELHI, (IANS) – Drug makers Cipla and Glenmark are recalling their products from the US market due to manufacturing ...

Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the ...

Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the ...

In line with GPL's commitment to become carbon neutral by 2030, this investment will enhance the share of renewable power in its operation. The acquisition of shares will enable GPL to invest in ...

Cipla and Glenmark Pharmaceuticals are recalling specific products from the US market due to distinct manufacturing issues, the latest Enforcement Report issued by the US Food and Drug ...

Glenmark Life Sciences Q4 Results Live : Glenmark Life Sciences declared their Q4 results on 25 Apr, 2024. The topline decreased by 13.64% & the profit decreased by 33.08% YoY. As compared to the ...

"We concluded the financial year on a positive note with revenue growth of 5.6 per cent on a full year basis, driven by regulated markets in external business," Glenmark Life Sciences MD & CEO Yasir ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

BENGALURU (Reuters) - Indian drugmaker Glenmark Life Sciences posted its first drop in profit for six quarters on Thursday as its mainstay active pharmaceutical ingredients (API) business was hurt ...

Glenmark Pharmaceuticals Ltd share price was up by 0.57% from the previous closing price of ₹1,015.75. Who are peers of Glenmark Pharmaceuticals Ltd? The peers of Glenmark Pharmaceuticals Ltd ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...